Risk Management Plans (RMPs) are a key part of Health Canada\u2019s approach to ensure drug safety throughout the drug life-cycle. RMPs help identify and assess new safety risks, define how those risks will be monitored and outline measures to minimize them, when uncertainties exist.<\/p>\n\n\n\n
With Health Canada\u2019s updated guidance made effective on July 1, 2025, Canadian Market Authorization Holders (MAHs) must ensure RMP strategies are up to date, and are aligned with the new Canadian requirements \u2013 not only during NDS\/SNDS submission, but throughout the product lifecycle.<\/p>\n\n\n\n
Why RMPs matter<\/u>?<\/span> <\/strong><\/p>\n\n\n\n RMPs are designed to:<\/p>\n\n\n\n <\/p>\n\n\n\n Not all products require an RMP<\/strong>. An RMP is required when there is a significant degree of uncertainty<\/strong> about the risks associated with the drug, and when the drug presents a serious risk of injury to human health<\/strong> that warrants measures to reduce the likelihood of an injury.<\/p>\n\n\n\n When Are RMP Updates Required?<\/u><\/strong><\/p>\n\n\n\n Health Canada does not expect routine or scheduled RMP updates. Instead, updates are required when meaningful changes occur<\/strong>, such as:<\/p>\n\n\n\n <\/p>\n\n\n\n Common <\/strong><\/span>Challenges with Canadian RMPs<\/u><\/strong><\/p>\n\n\n\n While the context of the RMP deficiencies is specific to the particular RMP in question and the MAH operational model. We highlight here a few of the most frequent definiens cited by Health Canada regarding RMP practices:<\/p>\n\n\n\n Proactively addressing these elements can help reduce follow-up requests, review delays and submission rejection. <\/p>\n\n\n\n Best Practices for RMP Lifecycle Management<\/u><\/strong><\/p>\n\n\n\n To maintain compliance and support efficient regulatory interactions, MAHs should:<\/p>\n\n\n\n A structured and proactive approach helps ensure that RMPs remain compliant with Health Canada expectations through the product lifecycle.<\/p>\n\n\n\n Zenith PV experts can support you develop\/update your RMP in full compliance with local regulatory requirements to meet Health Canada expectations and ensure your continued operational success to fulfill all PV commitments. <\/p>\n\n\n\n <\/p>\n","protected":false},"excerpt":{"rendered":" Risk Management Plans (RMPs) are a key part of Health Canada\u2019s approach to ensure drug safety throughout the drug life-cycle. RMPs help identify and assess new safety risks, define how […]<\/p>\n","protected":false},"author":2,"featured_media":2370,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18],"tags":[],"class_list":["post-3696","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-all-articles"],"yoast_head":"\n\n
\n
\n
\n